This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Flexible budgeting adapts to life changes, helping you reallocate resources without derailing your overall plans and savings targets.
21,189 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Insiders are quietly loading up on fintech stocks even as markets wobble. This article explains what those moves coul...
A 2025 NAHREP study finds Hispanic households added 441,000 owner-occupied homes, the largest annual gain on record, ...
A Nurix Therapeutics insider recently sold shares, drawing attention from investors. This article breaks down the mov...
When a company in niche hardware makes a bold strategic move, the stock can leap. This piece explains how unusual mac...
A watershed moment hit crypto markets as bitcoin etfs shed $630m in one day. This article breaks down what drove the ...
A large fund snapped up 1.2 million Vir Biotechnology shares as the stock doubled this past year. Here’s how to read ...
As markets heat up this summer, here's this tech stock stands out for its AI-focused growth story, solid finances, an...
Long-term investing isn’t about chasing the hottest trend. It’s about finding durable brands that can pay and grow di...
Bitcoin recently touched a six-week low as volatility remained elevated. This piece explains why bitcoin traders incr...
Want income that compounds over time? These high-yield energy stocks offer reliable payouts and growth potential. Lea...
Berkshire Hathaway is positioned to become a much larger Alphabet holder as the tech giant pursues a bold AI financin...